Cargando…
Natural History of Leigh Syndrome: A Study of Disease Burden and Progression
OBJECTIVE: This observational cohort study aims to quantify disease burden over time, establish disease progression rates, and identify factors that may determine the disease course of Leigh syndrome. METHODS: Seventy‐two Leigh syndrome children who completed the Newcastle Paediatric Mitochondrial D...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534328/ https://www.ncbi.nlm.nih.gov/pubmed/34716721 http://dx.doi.org/10.1002/ana.26260 |
_version_ | 1784802518215163904 |
---|---|
author | Lim, Albert Z. Ng, Yi Shiau Blain, Alasdair Jiminez‐Moreno, Cecilia Alston, Charlotte L. Nesbitt, Victoria Simmons, Louise Santra, Saikat Wassmer, Evangeline Blakely, Emma L. Turnbull, Doug M. Taylor, Robert W. Gorman, Gráinne S. McFarland, Robert |
author_facet | Lim, Albert Z. Ng, Yi Shiau Blain, Alasdair Jiminez‐Moreno, Cecilia Alston, Charlotte L. Nesbitt, Victoria Simmons, Louise Santra, Saikat Wassmer, Evangeline Blakely, Emma L. Turnbull, Doug M. Taylor, Robert W. Gorman, Gráinne S. McFarland, Robert |
author_sort | Lim, Albert Z. |
collection | PubMed |
description | OBJECTIVE: This observational cohort study aims to quantify disease burden over time, establish disease progression rates, and identify factors that may determine the disease course of Leigh syndrome. METHODS: Seventy‐two Leigh syndrome children who completed the Newcastle Paediatric Mitochondrial Disease Scale (NPMDS) at baseline at 3.7 years (interquartile range [IQR] = 2.0–7.6) and follow‐up assessments at 7.5 years (IQR = 3.7–11.0) in clinics were enrolled. Eighty‐two percent of this cohort had a confirmed genetic diagnosis, with pathogenic variants in the MT‐ATP6 and SURF1 genes being the most common cause. The total NPMDS scores denoted mild (0–14), moderate (15–25), and severe (>25) disease burden. Detailed clinical, neuroradiological, and molecular genetic findings were also analyzed. RESULTS: The median total NPMDS scores rose significantly (Z = −6.9, p < 0.001), and the percentage of children with severe disease burden doubled (22% → 42%) over 2.6 years of follow‐up. Poor function (especially mobility, self‐care, communication, feeding, and education) and extrapyramidal features contributed significantly to the disease burden (τ (b) ≈ 0.45–0.68, p < 0.001). These children also deteriorated to wheelchair dependence (31% → 57%), exclusive enteral feeding (22% → 46%), and one‐to‐one assistance for self‐care (25% → 43%) during the study period. Twelve children (17%) died after their last NPMDS scores were recorded. These children had higher follow‐up NPMDS scores (disease burden; p < 0.001) and steeper increase in NPMDS score per annum (disease progression; p < 0.001). Other predictors of poor outcomes include SURF1 gene variants (p < 0.001) and bilateral caudate changes on neuroimaging (p < 0.01). INTERPRETATION: This study has objectively defined the disease burden and progression of Leigh syndrome. Our analysis has also uncovered potential influences on the trajectory of this neurodegenerative condition. ANN NEUROL 2022;91:117–130 |
format | Online Article Text |
id | pubmed-9534328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95343282022-10-11 Natural History of Leigh Syndrome: A Study of Disease Burden and Progression Lim, Albert Z. Ng, Yi Shiau Blain, Alasdair Jiminez‐Moreno, Cecilia Alston, Charlotte L. Nesbitt, Victoria Simmons, Louise Santra, Saikat Wassmer, Evangeline Blakely, Emma L. Turnbull, Doug M. Taylor, Robert W. Gorman, Gráinne S. McFarland, Robert Ann Neurol Research Articles OBJECTIVE: This observational cohort study aims to quantify disease burden over time, establish disease progression rates, and identify factors that may determine the disease course of Leigh syndrome. METHODS: Seventy‐two Leigh syndrome children who completed the Newcastle Paediatric Mitochondrial Disease Scale (NPMDS) at baseline at 3.7 years (interquartile range [IQR] = 2.0–7.6) and follow‐up assessments at 7.5 years (IQR = 3.7–11.0) in clinics were enrolled. Eighty‐two percent of this cohort had a confirmed genetic diagnosis, with pathogenic variants in the MT‐ATP6 and SURF1 genes being the most common cause. The total NPMDS scores denoted mild (0–14), moderate (15–25), and severe (>25) disease burden. Detailed clinical, neuroradiological, and molecular genetic findings were also analyzed. RESULTS: The median total NPMDS scores rose significantly (Z = −6.9, p < 0.001), and the percentage of children with severe disease burden doubled (22% → 42%) over 2.6 years of follow‐up. Poor function (especially mobility, self‐care, communication, feeding, and education) and extrapyramidal features contributed significantly to the disease burden (τ (b) ≈ 0.45–0.68, p < 0.001). These children also deteriorated to wheelchair dependence (31% → 57%), exclusive enteral feeding (22% → 46%), and one‐to‐one assistance for self‐care (25% → 43%) during the study period. Twelve children (17%) died after their last NPMDS scores were recorded. These children had higher follow‐up NPMDS scores (disease burden; p < 0.001) and steeper increase in NPMDS score per annum (disease progression; p < 0.001). Other predictors of poor outcomes include SURF1 gene variants (p < 0.001) and bilateral caudate changes on neuroimaging (p < 0.01). INTERPRETATION: This study has objectively defined the disease burden and progression of Leigh syndrome. Our analysis has also uncovered potential influences on the trajectory of this neurodegenerative condition. ANN NEUROL 2022;91:117–130 John Wiley & Sons, Inc. 2021-11-12 2022-01 /pmc/articles/PMC9534328/ /pubmed/34716721 http://dx.doi.org/10.1002/ana.26260 Text en © 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Lim, Albert Z. Ng, Yi Shiau Blain, Alasdair Jiminez‐Moreno, Cecilia Alston, Charlotte L. Nesbitt, Victoria Simmons, Louise Santra, Saikat Wassmer, Evangeline Blakely, Emma L. Turnbull, Doug M. Taylor, Robert W. Gorman, Gráinne S. McFarland, Robert Natural History of Leigh Syndrome: A Study of Disease Burden and Progression |
title | Natural History of Leigh Syndrome: A Study of Disease Burden and Progression |
title_full | Natural History of Leigh Syndrome: A Study of Disease Burden and Progression |
title_fullStr | Natural History of Leigh Syndrome: A Study of Disease Burden and Progression |
title_full_unstemmed | Natural History of Leigh Syndrome: A Study of Disease Burden and Progression |
title_short | Natural History of Leigh Syndrome: A Study of Disease Burden and Progression |
title_sort | natural history of leigh syndrome: a study of disease burden and progression |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534328/ https://www.ncbi.nlm.nih.gov/pubmed/34716721 http://dx.doi.org/10.1002/ana.26260 |
work_keys_str_mv | AT limalbertz naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT ngyishiau naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT blainalasdair naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT jiminezmorenocecilia naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT alstoncharlottel naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT nesbittvictoria naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT simmonslouise naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT santrasaikat naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT wassmerevangeline naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT blakelyemmal naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT turnbulldougm naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT taylorrobertw naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT gormangrainnes naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression AT mcfarlandrobert naturalhistoryofleighsyndromeastudyofdiseaseburdenandprogression |